Lotus Clinical Research recapitalized by DFW Capital Partners

Sep. 2018

Client: Lotus Clinical Research is the preeminent analgesic specialty clinical research organization (CRO)

Role: Edgemont Partners acted as exclusive financial advisor to Lotus Clinical Research in its recapitalization by DFW Capital

Location: Pasadena, CA

Sector: Pharmaceutical Services

Lead Banker: David Blume

lotus clinical research logo

recapitalized by

dfw capital partners logo
Get In Touch